2020 Virtual Poster Presentations
P01: Predicting pH Equilibrium in Cell Culture Processes by Semi-Mechanistic Empirical Models; Presented by Anisur R., AbbVie
P02: A Scalable Harvest for Recombinant Adeno-Associated Virus Purification; Presented by Eva G., Asklepios Biopharmaceuticals
P03: Development of an Analytical High-Throughput Purification Method for Cell Culture Supernatants and Demonstration of Comparable Product Quality; Presented by Tracy D., AstraZeneca
P04: Determination of Concentration and Viability of Pichia pastoris and Saccharomyces cerevisae in Culture Using Vi-CELL BLU; Presented by Natalia S., Beckman Coulter Life Sciences
P05: Rapid Generation of Production Cell Lines with Superior Titers and >99% Monoclonality for Complex Antibody Molecules; Presented by Anupam S., Berkeley Lights, Inc.
P06: Characterization of Monoclonal Antibodies with Multi-Technique Approach of FTIR, RAMAN and ROA; Presented by Yelena P., BioTools, Inc.
P07: Formulation and Characterization of Proteolytic Enzyme-Loaded Liposomes for the Treatment of Hypertrophic Scars; Presented by Rachana S., Creighton University
P08: Innovation in Biomanufacturing Using Microfluidics; Presented by Natalia B., Florida International University
P09: Automated Low Volume Subvisible Particle Analysis with the HORIZON System; Presented by Rick G., Halo Labs
P10: Protein or Not? Advanced, High Throughput Subvisible Particle Characterization with Fluorescent ID; Presented by Rick G., Halo Labs
P11: A Nanoplasmonic Biosensor for Online Real-Time Monitoring of IgG Titers During Bioprocessing; Presented by Thuy T., Linkoping University
P12: Small-Scale Screening of Serum Free Medium Formulations of T Cell Culture for CAR-T Applications; Presented by Maureen H., Novartis Pharmaceuticals Corporation
P13: Addressing Large-Scale Therapeutic Virus Production Using High Quality Grade PEI-Based Transfection Reagents; Presented by Katarina B., Polyplus-transfection
P14: Next-Generation Transfection Reagent for Large Scale AAV Manufacturing; Presented by Megane D., Polyplus-transfection
P15: Affinity Membrane for Rapid, High-Recovery Concentration and Purification of Viral Vectors; Presented by Jinxiang Z., Purilogics, LLC
P16: New Tool for the Next Generation of Antibody Purification: Case Study Using Novel Protein A Affinity Chromatographic Membrane Technology; Presented by Graham T., Purilogics, LLC
P17: Novel Multimodal and Weak Anion-Exchange Membrane Chromatography Columns for Biologics Purification; Presented by Daniel H., Purilogics, LLC
P18: Demonstrating Comparability Between Ultracentrifugation Versus Chromatography-Based Purification Platforms for Adeno-Associated Viruses (AAV); Presented by Teresa V., Tenaya Therapeutics
P19: Impacts on Product Quality Attributes of Monoclonal Antibodies Produced in CHO Cell Bioreactor Cultures During Intentional Mycoplasma Contamination Events; Presented by Erica B., U.S. Food and Drug Administration
P20: Understanding Virus Filtration in a Continuous Manufacturing Process; Presented by Sarah J., U.S. Food and Drug Administration
P21: AAV Genome Ejection, Capsid Stability, Aggregation, and Titer with High-Throughput Screening on Uncle; Presented by Kevin L., Unchained Labs
P22: Automate Buffer Exchange to Fast Track Formulation Development and Optimization; Presented by Donna C., Unchained Labs
P23: Particle Characterization and Identification with Hound; Presented by Joe B., Unchained Labs
P24: Take Low Volume Protein Quantification Anywhere with Performance Verification on Big Lunatic; Presented by Nelis D., Unchained Labs
P25: Aggregation of Antibody-Drug Conjugates: The Light Scattering Toolbox for Screening and Characterization; Presented by John C., Wyatt Technology
P26: Next Steps in AAV Characterization via Light Scattering Measuring AAV Critical Quality Attributes; Presented by John C., Wyatt Technology
P27: Simplifying Cell Model Development for CHO Cell Culture with an Advanced Control Bioreactor System Employing Dual In-Line Soft Sensor Technology to Tightly Regulate Glucose; Presented by John R., Yokogawa Corporation of America
P28: Employing Multi-Attribute Method (MAM) for Automated Quality Monitoring of Biotherapeutics; Presented by Maurizio B., Genedata, Inc.